annual current liabilities:
$39.75M+$20.63M(+107.83%)Summary
- As of today (June 17, 2025), AKRO annual total current liabilities is $39.75 million, with the most recent change of +$20.63 million (+107.83%) on December 31, 2024.
- During the last 3 years, AKRO annual current liabilities has risen by +$14.63 million (+58.21%).
- AKRO annual current liabilities is now at all-time high.
Performance
AKRO Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$42.44M+$2.69M(+6.75%)Summary
- As of today (June 17, 2025), AKRO quarterly total current liabilities is $42.44 million, with the most recent change of +$2.69 million (+6.75%) on March 31, 2025.
- Over the past year, AKRO quarterly current liabilities has increased by +$12.18 million (+40.25%).
- AKRO quarterly current liabilities is now -1.97% below its all-time high of $43.29 million, reached on September 30, 2024.
Performance
AKRO quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AKRO Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +107.8% | +40.3% |
3 y3 years | +58.2% | +92.1% |
5 y5 years | +324.3% | +412.2% |
AKRO Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +108.3% | -2.0% | +154.5% |
5 y | 5-year | at high | +324.3% | -2.0% | +412.2% |
alltime | all time | at high | >+9999.0% | -2.0% | +1712.1% |
AKRO Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $42.44M(+6.8%) |
Dec 2024 | $39.75M(+107.8%) | $39.75M(-8.2%) |
Sep 2024 | - | $43.29M(+38.9%) |
Jun 2024 | - | $31.17M(+3.0%) |
Mar 2024 | - | $30.26M(+58.2%) |
Dec 2023 | $19.13M(+0.2%) | $19.13M(-32.8%) |
Sep 2023 | - | $28.45M(+31.7%) |
Jun 2023 | - | $21.60M(+29.5%) |
Mar 2023 | - | $16.68M(-12.6%) |
Dec 2022 | $19.08M(-24.1%) | $19.08M(-24.4%) |
Sep 2022 | - | $25.24M(-5.4%) |
Jun 2022 | - | $26.70M(+20.8%) |
Mar 2022 | - | $22.10M(-12.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $25.13M(+91.7%) | $25.13M(+6.7%) |
Sep 2021 | - | $23.54M(+43.0%) |
Jun 2021 | - | $16.46M(+62.4%) |
Mar 2021 | - | $10.14M(-22.7%) |
Dec 2020 | $13.11M(+39.9%) | $13.11M(+9.1%) |
Sep 2020 | - | $12.01M(+15.6%) |
Jun 2020 | - | $10.39M(+25.4%) |
Mar 2020 | - | $8.29M(-11.6%) |
Dec 2019 | $9.37M(+300.0%) | $9.37M(+39.3%) |
Sep 2019 | - | $6.72M(+41.9%) |
Jun 2019 | - | $4.74M(+97.2%) |
Mar 2019 | - | $2.40M(+2.6%) |
Dec 2018 | $2.34M(+955.0%) | $2.34M |
Dec 2017 | $222.00K | - |
FAQ
- What is Akero Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Akero Therapeutics?
- What is Akero Therapeutics annual current liabilities year-on-year change?
- What is Akero Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Akero Therapeutics?
- What is Akero Therapeutics quarterly current liabilities year-on-year change?
What is Akero Therapeutics annual total current liabilities?
The current annual current liabilities of AKRO is $39.75M
What is the all time high annual current liabilities for Akero Therapeutics?
Akero Therapeutics all-time high annual total current liabilities is $39.75M
What is Akero Therapeutics annual current liabilities year-on-year change?
Over the past year, AKRO annual total current liabilities has changed by +$20.63M (+107.83%)
What is Akero Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of AKRO is $42.44M
What is the all time high quarterly current liabilities for Akero Therapeutics?
Akero Therapeutics all-time high quarterly total current liabilities is $43.29M
What is Akero Therapeutics quarterly current liabilities year-on-year change?
Over the past year, AKRO quarterly total current liabilities has changed by +$12.18M (+40.25%)